Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03220204 · ClinicalTrials.gov registry record · NA

Researching Emotions And Cardiac Health: Phase III

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03220204: Completed NA study, sponsored by Massachusetts General Hospital.

NCT03220204 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03220204, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The focus of this study is to examine the feasibility, acceptability, and preliminary impact of a 12-week, telephone-delivered, positive psychology (PP)-based health behavior intervention in a group of patients with mild to moderate heart failure (HF), compared to a motivational interviewing- (MI-) based education condition and treatment as usual (TAU).

Primary Outcome

Feasibility will be measured by examining the number of completed exercises for individuals randomized to the Positive Psychology (PP)-based intervention.

Interventions

  • BEHAVIORAL PP-based health behavior intervention
  • BEHAVIORAL MI-based educational control condition

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-09-01
Est. Completion 2019-09-09
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT03220204 record still lists

NCT03220204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which PP-based health behavior intervention is the first listed.

NCT03220204 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03220204 about?

NCT03220204 is a clinical study titled "Researching Emotions And Cardiac Health: Phase III". The focus of this study is to examine the feasibility, acceptability, and preliminary impact of a 12-week, telephone-delivered, positive psychology (PP)-based health behavior intervention in a group of patients with mild to moderate heart failure (HF), compared to a motivational interviewing- (MI-) ...

What is the current status of trial NCT03220204?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-09-01. Estimated completion is 2019-09-09.

What interventions are being tested in trial NCT03220204?

The interventions under investigation include: PP-based health behavior intervention (BEHAVIORAL), MI-based educational control condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT03220204?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03220204's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03220204, the US trial registry maintained by the National Library of Medicine. NCT03220204 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.